BASECARE-B (02170) Announces February 2026 Monthly Securities Movements
Bulletin Express
Mar 04
On 4 March 2026, Suzhou Basecare Medical Corporation Limited (BASECARE-B, stock code 02170) published its monthly return for the period ended 28 February 2026. Total authorized/registered share capital stood at 273.53 million RMB, consisting of 82.71 million H shares, 183.18 million domestic shares, and 7.63 million unlisted foreign shares. There were no increases or decreases in any share classes during the month.
According to the return, no share repurchases, share redemptions, or issues under options, warrants, or convertible instruments were recorded. The company also confirmed that it met the required public float threshold for H shares in the reported period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.